Get the Stockscreener App
1.84
1.66%
0.03
After Hours:
1.78
-0.06
-3.26%
Cabaletta Bio Inc stock is traded at $1.84, with a volume of 1.57M.
It is up +1.66% in the last 24 hours and up +38.35% over the past month.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.
See More
Previous Close:
$1.81
Open:
$1.8
24h Volume:
1.57M
Relative Volume:
0.89
Market Cap:
$168.30M
Revenue:
-
Net Income/Loss:
$-67.68M
P/E Ratio:
-1.1084
EPS:
-1.66
Net Cash Flow:
$-54.24M
1W Performance:
+8.24%
1M Performance:
+38.35%
6M Performance:
-3.66%
1Y Performance:
-54.34%
1-Day Range:
$1.73
$1.87
1-Week Range:
$1.625
$1.87
52-Week Range:
$0.9857
$5.46
Cabaletta Bio Inc Stock (CABA) Company Profile
Name
Cabaletta Bio Inc
Sector
Industry
Phone
(267) 759-3100
Address
2929 ARCH STREET, PHILADELPHIA, PA
Compare CABA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CABA
Cabaletta Bio Inc
|
1.84 | 159.15M | 0 | -67.68M | -54.24M | -1.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Cabaletta Bio Inc Stock (CABA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-19-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-10-24 | Initiated | UBS | Buy |
| Feb-05-24 | Initiated | Jefferies | Buy |
| Nov-29-23 | Initiated | William Blair | Outperform |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-19-23 | Initiated | Stifel | Buy |
| Sep-05-23 | Initiated | Citigroup | Buy |
| Jul-18-23 | Initiated | Guggenheim | Buy |
| Jan-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-30-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-08-21 | Initiated | Wells Fargo | Overweight |
| Oct-19-21 | Resumed | Morgan Stanley | Overweight |
| Jun-30-21 | Initiated | Mizuho | Buy |
| Jan-08-21 | Initiated | Chardan Capital Markets | Buy |
| Oct-13-20 | Initiated | H.C. Wainwright | Buy |
| Nov-19-19 | Initiated | Cowen | Outperform |
| Nov-19-19 | Initiated | Evercore ISI | Outperform |
| Nov-19-19 | Initiated | Morgan Stanley | Overweight |
View All
Cabaletta Bio Inc Stock (CABA) Latest News
Cabaletta Bio Advances Autoimmune Therapy, Sets Strategic Goals for 2025 - MSN
Certain Pre-funded Warrants of Cabaletta Bio, Inc. are subject to a Lock-Up Agreement Ending on 10-SEP-2025. - MarketScreener
Certain Stock Options of Cabaletta Bio, Inc. are subject to a Lock-Up Agreement Ending on 10-SEP-2025. - MarketScreener
Certain Common Stock of Cabaletta Bio, Inc. are subject to a Lock-Up Agreement Ending on 10-SEP-2025. - MarketScreener
Nuveen LLC Makes New $602,000 Investment in Cabaletta Bio, Inc. $CABA - MarketBeat
Does Cabaletta Bio Inc. have pricing power2025 Growth vs Value & Weekly Market Pulse Alerts - Lancaster City Council
Is Cabaletta Bio Inc.’s ROE strong enoughPortfolio Risk Summary & High Conviction Buy Zone Alerts - Lancaster City Council
Bullish Divergence Spotted in Cabaletta Bio Inc. Momentum2025 Short Interest & High Yield Stock Recommendations - beatles.ru
Is Cabaletta Bio Inc. Starting a New UptrendTreasury Yields & Reliable Breakout Forecasts - beatles.ru
Almitas Capital LLC Takes Position in Cabaletta Bio, Inc. $CABA - MarketBeat
What analysts say about Cabaletta Bio Inc. stockDollar Strength & High Accuracy Swing Trade Signals - 뉴스영
What earnings revisions data tells us about Cabaletta Bio Inc.Market Trend Summary & Free Weekly Watchlist of Top Performers - Newser
What’s the recovery path for long term holders of Cabaletta Bio Inc.Weekly Profit Summary & Free Weekly Chart Analysis and Trade Guides - Newser
What are Cabaletta Bio Inc.’s recent SEC filings showingMarket Growth Summary & High Accuracy Swing Entry Alerts - خودرو بانک
Why is Cabaletta Bio Inc. stock going up2025 Momentum Check & Capital Protection Trade Alerts - خودرو بانک
Is Cabaletta Bio Inc. stock risky to hold nowLayoff News & Free Real-Time Volume Trigger Notifications - خودرو بانک
CABA: Cantor Fitzgerald Reiterates Overweight Rating Today | CAB - GuruFocus
Automated trading signals detected on Cabaletta Bio Inc.Weekly Trade Review & AI Forecast Swing Trade Picks - Newser
Is Cabaletta Bio Inc. stock poised for growthBond Market & Growth-Oriented Investment Plans - Newser
What moving averages say about Cabaletta Bio Inc.2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser
Is Cabaletta Bio Inc. stock reversal real or fakeMarket Trend Report & Weekly Top Gainers Trade List - Newser
Should I average down on Cabaletta Bio Inc. stockJuly 2025 Trade Ideas & AI Driven Price Predictions - خودرو بانک
What’s the outlook for Cabaletta Bio Inc.’s sector2025 Analyst Calls & Risk Managed Investment Strategies - beatles.ru
Developing predictive dashboards with Cabaletta Bio Inc. dataPortfolio Value Summary & Short-Term Swing Trade Alerts - Newser
What’s the beta of Cabaletta Bio Inc. stock2025 Year in Review & Daily Technical Stock Forecast Reports - خودرو بانک
Cabaletta Bio, Inc. (NASDAQ:CABA) Receives $14.43 Consensus Price Target from Analysts - MarketBeat
Using economic indicators to assess Cabaletta Bio Inc. potentialJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - Newser
Is Cabaletta Bio Inc. showing signs of accumulationChart Signals & Reliable Entry Point Alerts - Newser
Is Cabaletta Bio Inc. vulnerable to short sellersJuly 2025 Patterns & Stepwise Entry and Exit Trade Signals - خودرو بانک
Using data models to predict Cabaletta Bio Inc. stock movementJuly 2025 EndofMonth & Intraday High Probability Alerts - Newser
Is Cabaletta Bio Inc. being accumulated by smart money2025 Dividend Review & Intraday High Probability Setup Alerts - خودرو بانک
Live market analysis of Cabaletta Bio Inc.2025 Volatility Report & Intraday High Probability Alerts - Newser
Will Cabaletta Bio Inc. rebound enough to break even2025 Volatility Report & Free Technical Confirmation Trade Alerts - Newser
Analyzing drawdowns of Cabaletta Bio Inc. with statistical toolsBear Alert & Verified Swing Trading Watchlists - Newser
Signal strength of Cabaletta Bio Inc. stock in tech scannersWeekly Investment Recap & Free Growth Oriented Trading Recommendations - Newser
Technical signs of recovery in Cabaletta Bio Inc.July 2025 Outlook & Low Risk High Win Rate Picks - Newser
How to integrate Cabaletta Bio Inc. into portfolio analysis tools2025 Trading Recap & AI Driven Price Predictions - Newser
Cabaletta Bio Updates on Rese-cel Therapy Progress - TipRanks
Multi asset correlation models including Cabaletta Bio Inc.2025 Technical Overview & Real-Time Market Sentiment Alerts - Newser
What drives Cabaletta Bio Inc.’s stock priceEarnings Overview Summary & Weekly Watchlist of Top Performers - خودرو بانک
Cabaletta Bio Inc. stock daily chart insightsWall Street Watch & Weekly Top Stock Performers List - Newser
Does Cabaletta Bio Inc. show high probability of reboundWeekly Trade Report & Risk Controlled Swing Alerts - Newser
Is Cabaletta Bio Inc.’s ROIC above industry average2025 Earnings Surprises & Verified Momentum Stock Alerts - خودرو بانک
Is Cabaletta Bio Inc. stock a buy or sellPortfolio Update Report & Technical Pattern Based Signals - خودرو بانک
Cabaletta Bio Inc Stock (CABA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):